The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.
A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.
A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia.
A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount
Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent’s antibody drug for non-Hodgkin lymphoma.
Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood.